LENZ Therapeutics, Inc.
LENZ
$28.00
$0.692.53%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -58.88M | -52.40M | -47.74M | -49.77M | -60.81M |
| Total Depreciation and Amortization | 205.00K | 90.00K | 89.00K | 58.00K | 37.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.37M | 4.51M | 3.20M | 3.41M | 2.93M |
| Change in Net Operating Assets | 7.08M | 578.00K | -7.05M | -13.09M | -13.44M |
| Cash from Operations | -45.22M | -47.22M | -51.50M | -59.39M | -71.28M |
| Capital Expenditure | -938.00K | -685.00K | -578.00K | -468.00K | -319.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 3.22M | -54.93M | -153.01M | -154.01M | -127.12M |
| Cash from Investing | 2.28M | -55.61M | -153.59M | -154.48M | -127.44M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 27.18M | 56.42M | 29.93M | 83.70M | 83.65M |
| Repurchase of Common Stock | -- | -- | -150.00K | -150.00K | -150.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -13.00K | -2.00M | 115.45M | 113.54M |
| Cash from Financing | 27.18M | 56.40M | 27.78M | 199.00M | 197.04M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -15.76M | -46.43M | -177.32M | -14.87M | -1.69M |